FDA
-
-
-
-
-
-
-
ThermoGenesis Expands Board of Directors with the Appointments of Dr. Biao Xi and Dr. James Xu
-
-
-
-
-
-
-
ThermoGenesis Regains Compliance with Nasdaq Minimum Bid Price Requirement
-
-
-
-
-
-
-
ThermoGenesis Holdings Announces Financial Results for the Second Quarter Ended June 30, 2022 and Provides Corporate Update
-
-
-
-
-
-
-
ThermoGenesis Awarded NIH SBIR Phase I Grant to Develop Key Cell Processing Disposable for Quintessence Automated manufacturing of Gene-engineered Autologous Cell (GEAC) Therapies
-
-
-
-
-
-
-
ThermoGenesis Holdings Announces Financial Results for the Third Quarter Ended September 30, 2020 and Provides Corporate Update
-
-
-
-
-
-
-
ThermoGenesis Holdings Announces Change In Location Of 2020 Annual Meeting Of Stockholders
-
-
-
-
-
-
-
ThermoGenesis Receives Acknowledgement Letter from FDA Allowing Its SARS-CoV-2 (COVID-19) IgM/IgG Antibody Fast Detection Kit for Distribution
-
312,667 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

